InspireMD, Inc. (NSPR)

InspireMD Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-19.92	-18.49	-14.92	-10.54	-10.04
Depreciation & Amortization	0.23	0.19	0.16	0.15	0.16
Share-Based Compensation	4.49	2.35	1.58	0.61	0.33
Other Operating Activities	-1.18	0.41	-0.03	0.71	-0.25
Operating Cash Flow	-16.38	-15.54	-13.21	-9.08	-9.81
Capital Expenditures	-0.37	-0.47	-0.34	-0.07	-0.28
Change in Investments	-15.64	9	-22	0	0
Other Investing Activities	-0.08	-0.09	-0.11	-0.12	-0.1
Investing Cash Flow	-16.09	8.44	-22.46	-0.19	-0.39
Share Issuance / Repurchase	37.53	-0.14	35.03	16.4	6.34
Financing Cash Flow	37.53	-0.14	35.03	16.4	6.34
Exchange Rate Effect	-0.06	-0.13	-0.01	0	-0.01
Net Cash Flow	5.01	-7.37	-0.64	7.13	-3.87
Free Cash Flow	-16.75	-16.02	-13.55	-9.15	-10.09
Free Cash Flow Margin	-269.86%	-309.71%	-301.54%	-368.09%	-271.27%
Free Cash Flow Per Share	-0.69	-2.03	-1.84	-6.05	-72.45

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).